Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × OTHER_GOV × Other solid neoplasm × Clear all

Phase

Phase NA 6 Phase 2 6 Phase 1 3 Phase EARLY_PHASE1 1 Phase 3 1 Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

OTHER 6 INDUSTRY 3 OTHER_GOV 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 8 Gynecologic 4 Breast 3 Other hematologic neoplasm 2 Genitourinary 2 Tumor-Agnostic 1 Sarcoma 1 Other solid neoplasm 1 Head & Neck 1 CNS 1

Conditions

Advanced Solid Tumor 1

Interventions

spartalizumab 1 pembrolizumab 1 anlotinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03975036 2019-06-05

Clinical Study on the Second-line and Above Treatment of Advanced Solid Tumor With Anlotinib Combined With Pd-1 Antibody

Henan Cancer Hospital

Phase 2/3 Unknown

Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡